A short guide to histone deacetylases including recent progress on class II enzymes

다국어 초록 (Multilingual Abstract)

The interaction between histones and DNA is important for eukaryotic gene expression. A loose interaction caused, for example, by the neutralization of a positive charge on the histone surface by acetylation, induces a less compact chromatin structure, resulting in feasible accessibility of RNA polymerase and increased gene expression. In contrast, the formation of a tight chromatin structure due to the deacetylation of histone lysine residues on the surface by histone deacetylases enforces the interaction between the histones and DNA, which minimizes the chance of RNA polymerases contacting DNA, resulting in decreased gene expression. Therefore, the balance of the acetylation of histones mediated by histone acetylases (HATs) and histone deacetylases (HDACs) is an issue of transcription that has long been studied in relation to posttranslational modification. In this review, current knowledge of HDACs is briefly described with an emphasis on recent progress in research on HDACs, especially on class IIa HDACs.

참고문헌 (Reference)

1 Wu, R., "Zinc chelation with hydroxamate in histone deacetylases modulated by water access to the linker binding channel" 133 : 6110-6113, 2011

2 Buker, S. M., "Two different Argonaute complexes are required for siRNA generation and heterochromatin assembly in fission yeast" 14 : 200-207, 2007

3 Rundlett, S. E., "Transcriptional repression by UME6 involves deacetylation of lysine 5 of histone H4by RPD3" 392 : 831-835, 1998

4 Kazantsev, A. G., "Therapeutic application of histone deacetylase inhibitors for central nervous system disorders" 7 : 854-868, 2008

5 Vahid, F., "The role dietary of bioactive compounds on the regulation of histone acetylases and deacetylases : a review" 562 : 8-15, 2015

6 Wen, Y. D., "The histone deacetylase-3 complex contains nuclear receptor corepressors" 97 : 7202-7207, 2000

7 Guenther, M. G., "The SMRT and N-CoR corepressors are activating cofactors for histone deacetylase 3" 21 : 6091-6101, 2001

8 Brachmann, C. B., "The SIR2 gene family, conserved from bacteria to humans, functions in silencing, cell cycle progression, and chromosome stability" 9 : 2888-2902, 1995

9 Kalin, J. H., "Targeting the CoREST complex with dual histone deacetylase and demethylase inhibitors" 9 : 53-, 2018

10 Wu, J., "TUP1 utilizes histone H3/H2Bspecific HDA1 deacetylase to repress gene activity in yeast" 7 : 117-126, 2001

11 Lombardi, P. M., "Structure, mechanism, and inhibition of histone deacetylases and related metalloenzymes" 21 : 735-743, 2011

12 Finnin, M. S., "Structure of the histone deacetylase SIRT2" 8 : 621-625, 2001

13 Watson, P. J., "Structure of HDAC3bound to co-repressor and inositol tetraphosphate" 481 : 335-340, 2012

14 Park, S. Y., "Structural basis of the specific interaction of SMRT corepressor with histone deacetylase 4" 46 : 11776-11788, 2018

15 Shen, H., "Structural and histone binding ability characterization of the ARB2 domain of a histone deacetylase Hda1 from Saccharomyces cerevisiae" 6 : 33905-, 2016

16 Lee, J. H., "Structural and functional studies of the yeast class II Hda1 histone deacetylase complex" 391 : 744-757, 2009

17 Bottomley, M. J., "Structural and functional analysis of the human HDAC4catalytic domain reveals a regulatory structural zinc-binding domain" 283 : 26694-26704, 2008

18 Du, J., "Sirt5 is a NAD-dependent protein lysine demalonylase and desuccinylase" 334 : 806-809, 2011

19 Yao, R., "Scriptaid inhibits cell survival, cell cycle, and promotes apoptosis in multiple myeloma via epigenetic regulation of p21" 60 : 63-72, 2018

20 Poligone, B., "Romidepsin : evidence for its potential use to manage previously treated cutaneous T cell lymphoma" 6 : 1-12, 2011

21 엄광현, "Role of histone deacetylase 2 and its posttranslational modifications in cardiac hypertrophy" 생화학분자생물학회 48 (48): 131-138, 2015

22 Wang, A. H., "Regulation of histone deacetylase 4 by binding of 14-3-3proteins" 20 : 6904-6912, 2000

23 Grozinger, C. M., "Regulation of histone deacetylase 4 and 5and transcriptional activity by 14-3-3-dependent cellular localization" 97 : 7835-7840, 2000

24 Mathias, R. A., "Post-translational modifications regulate class IIa histone deacetylase(HDAC)function in health and disease" 14 : 456-470, 2015

25 Liu, K. Y., "Modification of epigenetic histone acetylation in hepatocellular carcinoma" 10 : 2018

26 Robyr, D., "Microarray deacetylation maps determine genome-wide functions for yeast histone deacetylases" 109 : 437-446, 2002

27 Mihaylova, M. M., "Metabolic reprogramming by class I and II histone deacetylases" 24 : 48-57, 2013

28 Kerckaert, J. P., "LAZ3, a novel zinc-finger encoding gene, is disrupted by recurring chromosome 3q27 translocations in human lymphomas" 5 : 66-70, 1993

29 Kao, H. Y., "Isolation of a novel histone deacetylase reveals that class I and class II deacetylases promote SMRTmediated repression" 14 : 55-66, 2000

30 Day, J. A., "Investigating the selectivity of metalloenzyme inhibitors" 56 : 7997-8007, 2013

31 Hudson, G. M., "Insights into the recruitment of class IIa histone deacetylases(HDACs)to the SMRT/NCoR transcriptional repression complex" 290 : 18237-18244, 2015

32 Fischle, W., "Human HDAC7 histone deacetylase activity is associated with HDAC3 in vivo" 276 : 35826-35835, 2001

33 Schuetz, A., "Human HDAC7 harbors a class IIa histone deacetylase-specific zinc binding motif and cryptic deacetylase activity" 283 : 11355-11363, 2008

34 Xiong, B., "Hos1 is a lysine deacetylase for the Smc3 subunit of cohesin" 20 : 1660-1665, 2010

35 Ayer, D. E., "Histone deacetylases : transcriptional repression with SINers and NuRDs" 9 : 193-198, 1999

36 Eckschlager, T, "Histone deacetylase inhibitors as anticancer drugs" 18 : 2017

37 Minucci, S., "Histone deacetylase inhibitors and the promise of epigenetic(and more)treatments for cancer" 6 : 38-51, 2006

38 Koutsounas, I., "Histone deacetylase inhibitors and pancreatic cancer: are there any promising clinical trials?" 19 : 1173-1181, 2013

39 Winkler, R., "Histone deacetylase 6(HDAC6)is an essential modifier of glucocorticoid-induced hepatic gluconeogenesis" 61 : 513-523, 2012

40 Hai, Y., "Histone deacetylase 10 structure and molecular function as a polyamine deacetylase" 8 : 15368-, 2017

41 Wu, J., "HDA2 and HDA3are related proteins that interact with and are essential for the activity of the yeast histone deacetylase HDA1" 98 : 4391-4396, 2001

42 Rundlett, S. E., "HDA1 and RPD3 are members of distinct yeast histone deacetylase complexes that regulate silencing and transcription" 93 : 14503-14508, 1996

43 Carmen, A. A., "HDA1 and HDA3 are components of a yeast histone deacetylase(HDA)complex" 271 : 15837-15844, 1996

44 Vogelauer, M., "Global histone acetylation and deacetylation in yeast" 408 : 495-498, 2000

45 Kurdistani, S. K., "Genome-wide binding map of the histone deacetylase Rpd3 in yeast" 31 : 248-254, 2002

46 Seto, E., "Erasers of histone acetylation : the histone deacetylase enzymes" 6 : a018713-, 2014

47 Fischle, W., "Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N-CoR" 9 : 45-57, 2002

48 Burli, R. W., "Design, synthesis, and biological evaluation of potent and selective class IIa histone deacetylase (HDAC) inhibitors as a potential therapy for Huntington’s disease" 56 : 9934-9954, 2013

49 Suraweera, A., "Combination therapy with histone deacetylase inhibitors(HDACi)for the treatment of cancer : achieving the full therapeutic potential of HDACi" 8 : 92-, 2018

50 Gao, L., "Cloning and functional characterization of HDAC11, a novel member of the human histone deacetylase family" 277 : 25748-25755, 2002

51 Hu, E., "Cloning and characterization of a novel human class I histone deacetylase that functions as a transcription repressor" 275 : 15254-15264, 2000

52 Parra, M., "ClassI. Ia HDACs—new insights into their functions in physiology and pathology" 282 : 1736-1744, 2015

53 Yang, X. J., "Class II histone deacetylases: from sequence to function, regulation, and clinical implication" 25 : 2873-2884, 2005

54 Verdin, E., "Class II histone deacetylases : versatile regulators" 19 : 286-293, 2003

55 Olins, D. E., "Chromatin history : our view from the bridge" 4 : 809-814, 2003

56 Frye, R. A., "Characterization of five human cDNAs with homology to the yeast SIR2 gene : Sir2-like proteins(sirtuins)metabolize NAD and may have protein ADP-ribosyltransferase activity" 260 : 273-279, 1999

57 Shaffer, A. L., "BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control" 13 : 199-212, 2000

58 Ye, B. H., "Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma" 262 : 747-750, 1993

59 McKinsey, T. A., "Activation of the myocyte enhancer factor-2 transcription factor by calcium/calmodulin-dependent protein kinasestimulated binding of 14-3-3 to histone deacetylase 5" 97 : 14400-14405, 2000

60 Glozak, M. A., "Acetylation/deacetylation modulates the stability of DNA replication licensing factor Cdt1" 284 : 11446-11453, 2009

61 Di Gennaro, E., "Acetylation of proteins as novel target for antitumor therapy : review article" 26 : 435-441, 2004

62 Guo, C., "ATM regulates ionizing radiationinduced disruption of HDAC1 : PP1 : Rb complexes" 19 : 504-510, 2007

63 Zhang, H., "A new functional domain of Bcl6 family that recruits histone deacetylases" 1540 : 188-200, 2001

64 Kasten, M. M., "A large protein complex containing the yeast Sin3p and Rpd3p transcriptional regulators" 17 : 4852-4858, 1997

65 Muslin, A. J., "14-3-3 proteins : regulation of subcellular localization by molecular interference" 12 : 703-709, 2000